NZ's AFT Pharma eyes best day in over 2 weeks on robust half-year results

AFT Pharmaceuticals

18/11/2021 03:04

** Shares of AFT pharmaceuticals  AFT.NZ  rise as much as
4.1% to NZ$4.840, post their biggest intraday percentage gain
since Nov. 2 
    ** Co says H1 revenue increased 14% to NZ$55.5 mln ($38.92
mln) from NZ$48.8 mln  urn:newsml:reuters.com:*:nGLF5GdTCQ
    ** Says net profit after tax more than tripled to NZ$4.2 mln
from NZ$1.2 mln 
    ** AFT reaffirms its FY guidance for operating profit
between NZ$18 mln and NZ$23 mln, with product launches and
improving market conditions expected to lead to a stronger H2 
    ** Shares hit their highest since Nov. 10 
    ** More than 51,600 shares change hands, compared with the
30-day average volume of about 28,850 shares 
    ** Stock had fallen 15.6% this year, as of last close

($1 = 1.4261 New Zealand dollars)

 (Reporting by Roushni Nair in Bangalore)
 ((Roushni.Nair@thomsonreuters.com))